Bristol-Myers Squibb's Opdivo + Yervoy Receives Expanded FDA Approval in Unresectable or Metastatic Melanoma Across BRAF Status1
January 24, 2016 at 06:55 AM EST
Bristol-Myers Squibb Company (NYSE: BMY) announced Saturday, that the U.S. Food and Drug Administration ...
